Please use this identifier to cite or link to this item: https://dspace.iiti.ac.in/handle/123456789/12011
Title: Dorzolamide suppresses PKCδ-TIRAP-p38 MAPK signaling axis to dampen the inflammatory response
Authors: Rajpoot, Sajjan
Jha, Hem Chandra
Baig, Mirza Saqib
Keywords: AP1;dorzolamide (DZD);macrophages;NF-κB;p38 MAPK;PKCδ;pro-inflammatory cytokines;sepsis;TIRAP
Issue Date: 2023
Publisher: Newlands Press Ltd
Citation: Rajpoot, S., Kumar, A., Gaponenko, V., Thurston, T. L. M., Mehta, D., Faisal, S. M., . . . Baig, M. S. (2023). Dorzolamide suppresses PKCδ-TIRAP-p38 MAPK signaling axis to dampen the inflammatory response. Future Medicinal Chemistry, 15(6), 533-554. doi:10.4155/fmc-2022-0260
Abstract: Background: Sepsis is a syndrome due to microbial infection causing impaired multiorgan function. Its underlying cause is immune dysfunction and macrophages play an essential role. Methods: TIRAP interaction with PKCδin macrophage was studied, revealing downstream signaling by Western blot and quantitative reverse transcriptase PCR. Dorzolamide (DZD) disrupting TIRAP-PKCδinteraction was identified by virtual screening and validated in vitro and in septic mice. Results: The study highlights the indispensable role of TIRAP-PKCδin p38 MAPK-activation, NF-κB- and AP-1-mediated proinflammatory cytokines expression, whereas DZD significantly attenuated the signaling. Conclusion: Targeting TIRAP-PKCδinteraction by DZD is a novel therapeutic approach for treating sepsis. © 2023 MS Baig.
URI: https://doi.org/10.4155/fmc-2022-0260
https://dspace.iiti.ac.in/handle/123456789/12011
ISSN: 1756-8919
Type of Material: Journal Article
Appears in Collections:Department of Biosciences and Biomedical Engineering

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: